| MeSH term | MeSH ID | Detail |
|---|---|---|
| Sclerosis | D012598 | 5 associated lipids |
| Scleroderma, Systemic | D012595 | 16 associated lipids |
| Salmonella Infections, Animal | D012481 | 9 associated lipids |
| Rhinitis | D012220 | 10 associated lipids |
| Retinal Vein Occlusion | D012170 | 2 associated lipids |
| Retinal Diseases | D012164 | 4 associated lipids |
| Retinal Detachment | D012163 | 10 associated lipids |
| Respiratory Insufficiency | D012131 | 10 associated lipids |
| Respiratory Hypersensitivity | D012130 | 18 associated lipids |
| Respiratory Distress Syndrome, Adult | D012128 | 15 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lumley P et al. | Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin. | 1991 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:1825385 |
| Mistry M and Nasjletti A | Role of TXA2 in the pathogenesis of severe angiotensin II-salt hypertension. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526469 |
| Koshihara Y and Fukuda M | Appearance of metabolic activities for arachidonate during development of mouse embryos. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526512 |
| Fuse I and Tai HH | Regulation of arachidonate release by G-proteins and protein kinase C in human platelets. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526540 |
| Houtz P and Tai HH | Enzyme immunoassay of thromboxane B2 using immobilized hapten and enzyme amplification. | 1989 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2526560 |
| FitzGerald GA et al. | Thromboxane biosynthesis and antagonism in humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959047 |
| Nowak J and FitzGerald GA | In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959050 |
| De Caterina R et al. | Characteristics of thromboxane production by the isolated-perfused rat heart. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2959082 |
| Samhoun MN et al. | Differential effect of vasoactive intestinal peptide on contractions induced by leukotriene D4, histamine, and acetylcholine in guinea pig lung parenchyma in vitro. | 1987 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:2960144 |
| Trimarco B et al. | Indomethacin blunts the late phase of nitroglycerin-induced coronary vasodilatation in dogs. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159220 |
| Shikano M et al. | Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159226 |
| Prosdocimi M et al. | Prostacyclin and thromboxane levels during cardiac ischemia in dogs. | 1985 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:3159235 |
| Fletcher JR et al. | Thromboxane inhibition in gram-negative sepsis fails to improve survival. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221586 |
| Socini A et al. | Fish oil administration lowers prostacyclin production and the antiaggregatory activity of aortic walls more effectively than platelet aggregation and thromboxane in the rat. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221591 |
| Hornstra G et al. | Dietary-fat-induced changes in the formation of prostanoids of the 2 and 3 series in relation to arterial thrombosis (rat) and atherosclerosis (rabbit). | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221593 |
| Tremoli E et al. | North Karelian study: changes in dietary fat reduce thromboxane B2 formation by platelets only in male subjects--preliminary report. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221594 |
| Basso N et al. | Gastric mucosal prostaglandin generation in rats with stress ulcer. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221618 |
| Foegh M et al. | Prostacyclin and thromboxane release from human peritoneal macrophages. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221630 |
| Westwick J et al. | Inhibition of thromboxane formation prevents endotoxin-induced renal fibrin deposition in jaundiced rats. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6221642 |
| Kangasaho M et al. | Formation of thromboxane B2 by platelets and concentrations of thromboxane B2 and 6-keto-prostaglandin F1 alpha in plasma after acute ethanol ingestion. | 1983 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:6303086 |